What happens after potential approval Assuming retatrutide eventually receives FDA approval, several practical questions arise for the research and clinical communities
Zhang Y, Parajuli KR, Fava GE et al (2019) GLP-1 receptor in pancreatic alpha-cells regulates glucagon secretion in a glucose-dependent bidirectional manner
CagriSema , combining semaglutide with cagrilintide (an amylin analog), represents another approach
Efficacy and tolerability of -galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo-controlled trial
consumer markets industry leader for PwC
Bottom of Form Read the full article: Authors: #KumaravelVelayutham #GomathiPanneerselvam #BalajiRamanathan Vaishya Raju Sage India Apollo Hospitals To view or add a comment, sign in SGLT-2 Inhibitors: Balancing Benefits and Risks in Type 2 Diabetes Care More than just glucose-lowering agents, SGLT-2 inhibitors have transformed the management of type 2 diabetes delivering added benefits in weight loss, cardiovascular protection, and kidney health